Cargando…
Biomarkers in Cardiology – Part 1 – In Heart Failure and Specific Cardiomyopathies
Cardiovascular diseases are the leading causes of mortality and morbidity in Brazil. The primary and secondary preventions of those diseases are a priority for the health system and require multiple approaches to increase their effectiveness. Biomarkers are tools used to more accurately identify hig...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290735/ https://www.ncbi.nlm.nih.gov/pubmed/25590924 http://dx.doi.org/10.5935/abc.20140184 |
Ejemplares similares
-
Biomarkers in Cardiology - Part 2: In Coronary Heart Disease, Valve
Disease and Special Situations
Publicado: (2015) -
The tobacco endgame—eradicating a worsening epidemic: A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation
por: Willett, Jeffrey, et al.
Publicado: (2021) -
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations
por: Whelton, Paul K, et al.
Publicado: (2022) -
Taking a stand against air pollution – the impact on cardiovascular disease: A Joint Opinion from the World Heart Federation, American College of Cardiology, American Heart Association, and the European Society of Cardiology
por: Brauer, Michael, et al.
Publicado: (2021) -
The Year in Cardiology 2015: Heart Failure
por: Komajda, Michel, et al.
Publicado: (2016)